HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemonucleolysis. Eight- to ten-year follow-up evaluation.

Abstract
This study involves eight- to ten-year follow-up results of chymopapain injection for severe sciatic pain secondary to a herniating nucleus pulposus. Two hundred sixty-three of 265 patients were available for a one- to two-year examination, but only 130 responded to the survey. Forty-five percent of patients were female, 55% were male. The mean age was 40. Seventeen percent were worker's compensation cases. Of the 263 patients at one- to two-year follow-up examination, 18.6% showed excellent response, 43.7% good, 21.7% fair, 14.1% no improvement, and 1.9% were worse. Except for the 14% of cases with intractable pain, all were given three months conservative treatment prior to injection. Of the 130 patients in the long-term study, 51.5% had excellent improvement, 20% good, 12.3% fair, 12.3% no improvement, and 3.8% were worse. While 50% of these patients said that they had some pain, 72% reported very active life-styles, only 2.3% stating they were completely inactive. Only 13.1% on the patients followed for eight to ten years reported unemployment because of their low-back condition. Patients who had had surgical treatment prior to injection showed only 50% good to excellent results as compared to 73% overall. Of 43 failures treated by open surgery following injection, only five had free fragments in the spinal canal; one-third had retained intradiscal fragments; one-third had nerve root adherence of discogenic origin; the others had lateral recess stenosis. The good results generally persisted over the eight- to ten-year period. Failures appeared within the first few months.
AuthorsG A Jabaay
JournalClinical orthopaedics and related research (Clin Orthop Relat Res) Issue 206 Pg. 24-31 (May 1986) ISSN: 0009-921X [Print] United States
PMID2940043 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Chymopapain
Topics
  • Adolescent
  • Adult
  • Aged
  • Chymopapain (therapeutic use)
  • Disability Evaluation
  • Female
  • Follow-Up Studies
  • Humans
  • Intervertebral Disc Displacement (drug therapy, rehabilitation)
  • Life Style
  • Lumbar Vertebrae
  • Male
  • Middle Aged
  • Occupations
  • Surveys and Questionnaires
  • Time Factors
  • United States
  • Workers' Compensation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: